Abstract
The COVID-19 pandemic has imposed many strenuous effects on the global economy, community, and medical infrastructure. Since the out- break, researchers and policymakers have scrambled to develop ways to identify how COVID-19 will affect specific sub-populations so that good public health decisions can be made. To this end, we adapt the work of Evensen et al [1] which introduces a SEIR model that incorporates an age-stratified contact matrix, a time dependent effective reproduction number R, and uses ensemble data assimilation to estimate model parameters. The adaptation is an extension of Evensen’s modeling framework, in which we model sub-populations with varying risks of contracting SARS-CoV-2 (the virus that causes COVID-19) in a particular state, each with a characteristic age-stratified contact matrix. In this work, we will focus on 9 U.S. states as well as the District of Columbia. We estimate the effective reproductive number as a function of time for our different sub-populations and then divide them into two groups: frontline communities (FLCs) and the complement (NFLCs). Our model will account for mixing both within populations (intra-population mixing) and between populations (inter-population mixing). Our data is conditioned on the daily numbers of accumulated deaths for each sub-population. We aim to test and demonstrate methodologies that can be used to assess critical metrics of the pandemic’s evolution which are difficult to directly measure. The output may ultimately be of use to measure the success or failures of the pandemic response and provide experts and policymakers a tool to create better plans for a future outbreak or pandemic. We consider the results of this work to be a reanalysis of pandemic evolution across differently affected sub-populations which may also be used to improve modeling and forecasts.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
C.~Sampson was supported by the US Office of Naval Research under grant N00014-18-1-2204. Daniel P. Maes was supported by the NSF GRFP DGE 1256260 grant. G.~Evensen was supported by internal funding from NORCE.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
No human trials were done.
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
The second author (CSS) is supported by the US Office of Naval Research under grant N00014- 18-1-2204. The third author (DPM) is supported by the NSF GRFP DGE 1256260. The seventh author (GE) was supported by internal funding from NORCE.
E-mail address: efleurantin2013{at}fau.edu
E-mail address: christian.sampson{at}gmail.com
E-mail address: dmaes{at}umich.edu
E-mail address: jkbenne6{at}asu.edu
E-mail address: fernandesnunez.t{at}northeastern.edu
E-mail address: sophiaemarx{at}gmail.com
E-mail address: geev{at}norceresearch.no
Data Availability
The data was obtained from the covid tracking project. https://covidtracking.com/
